Brandon Chen

Brandon Chen – Senior Research Scientist

Genomatica

Brandon Chen is the lead of strain engineering automation at Genomatica and one of the key contributors of 1,4-butanediol strain development that led to the successful commercialization of the renewable chemical. In the past four years, Brandon has led a team to develop molecular tools for bioengineering, pathway refactoring and molecular evolution of enzymes. Most recently, he has led a team to design and implement a LIMS-integrated system that enables data mining based on genetic variance.

Prior to his current position, Brandon led an R&D team at CODA Genomics (now Verdezyne) to develop the proprietary synthetic DNA technology “Thermodynamic DNA self-assembly.” He commercialized synthetic DNA product lines and completed a custom biologic library project, valued at $750K, for a top-five global pharmaceutical company. Brandon received his Ph.D. in microbiology and molecular genetics in 2004 and an M.B.A. in 2009 from University of California in Irvine.

While at the Paul Merage School of Business, his emphasis was on the biopharmaceutical and biotechnology industry. With a blend of science and business acumen, Brandon continues to seek innovative technologies that can transform our world and entrepreneurial ideas that foster business opportunities.